CAMBRIDGE, Mass., Jan. 2, 2019 /PRNewswire/ — AOBiome Therapeutics, Inc. (“AOBiome”), a leading clinical-stage microbiome company focusing on the …
CAMBRIDGE, Mass., Jan. 2, 2019 /PRNewswire/ — AOBiome Therapeutics, Inc. (“AOBiome”), a leading clinical-stage microbiome company focusing on the …